CPIX vs KEYS · rev $10.4M vs P/E 57, rev $4.98B
Cumberland Pharmaceuticals Inc (CPIX) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
CPIX currently screens at market cap $86.9M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the CPIX and KEYS stock pages for the full models.
Not investment advice.